Clearside Biomedical, Inc. (CLSD)
NASDAQ: CLSD · Real-Time Price · USD
0.8697
+0.0179 (2.10%)
May 2, 2025, 4:00 PM EDT - Market closed
Clearside Biomedical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 20.02 | 28.92 | 48.26 | 30.44 | 17.29 | Upgrade
|
| Cash & Short-Term Investments | 20.02 | 28.92 | 48.26 | 30.44 | 17.29 | Upgrade
|
| Cash Growth | -30.78% | -40.07% | 58.56% | 76.06% | -23.49% | Upgrade
|
| Receivables | 0.51 | 0.47 | - | 10 | - | Upgrade
|
| Prepaid Expenses | 0.73 | 0.72 | 0.7 | 0.92 | 0.72 | Upgrade
|
| Restricted Cash | - | - | 0.16 | 0.1 | 0.1 | Upgrade
|
| Other Current Assets | 0.01 | 0.01 | 0.28 | 0.68 | 0.01 | Upgrade
|
| Total Current Assets | 21.27 | 30.12 | 49.4 | 42.14 | 18.12 | Upgrade
|
| Property, Plant & Equipment | 3.82 | 3.87 | 1.87 | 0.61 | 0.94 | Upgrade
|
| Other Long-Term Assets | 0.03 | 0.03 | 0.03 | 0.16 | 0.26 | Upgrade
|
| Total Assets | 25.13 | 34.02 | 51.3 | 42.9 | 19.32 | Upgrade
|
| Accounts Payable | 1.45 | 2.21 | 1.05 | 0.94 | 2 | Upgrade
|
| Accrued Expenses | 2.97 | 4.17 | 4.18 | 3.31 | 1.58 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 0.99 | Upgrade
|
| Current Portion of Leases | 0.38 | 0.36 | 0.35 | 0.39 | 0.37 | Upgrade
|
| Current Unearned Revenue | - | 0.08 | 0.21 | - | 5 | Upgrade
|
| Total Current Liabilities | 4.79 | 6.81 | 5.78 | 4.64 | 9.94 | Upgrade
|
| Long-Term Debt | 51.77 | 41.99 | 33.98 | - | - | Upgrade
|
| Long-Term Leases | 0.33 | 0.65 | 0.94 | 0.29 | 0.62 | Upgrade
|
| Other Long-Term Liabilities | 7.09 | 0.48 | - | - | - | Upgrade
|
| Total Liabilities | 63.98 | 49.93 | 40.7 | 4.93 | 10.56 | Upgrade
|
| Common Stock | 0.08 | 0.06 | 0.06 | 0.06 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 316.34 | 304.95 | 298.98 | 293.41 | 264.58 | Upgrade
|
| Retained Earnings | -355.28 | -320.92 | -288.44 | -255.49 | -255.87 | Upgrade
|
| Total Common Equity | -38.86 | -15.91 | 10.61 | 37.98 | 8.76 | Upgrade
|
| Shareholders' Equity | -38.86 | -15.91 | 10.61 | 37.98 | 8.76 | Upgrade
|
| Total Liabilities & Equity | 25.13 | 34.02 | 51.3 | 42.9 | 19.32 | Upgrade
|
| Total Debt | 52.47 | 43 | 35.26 | 0.68 | 1.98 | Upgrade
|
| Net Cash (Debt) | -32.45 | -14.08 | 13 | 29.76 | 15.31 | Upgrade
|
| Net Cash Growth | - | - | -56.33% | 94.43% | -5.43% | Upgrade
|
| Net Cash Per Share | -0.44 | -0.23 | 0.22 | 0.50 | 0.33 | Upgrade
|
| Filing Date Shares Outstanding | 77.14 | 74.72 | 61.36 | 60.15 | 57.42 | Upgrade
|
| Total Common Shares Outstanding | 76.58 | 62.85 | 60.64 | 59.72 | 51.86 | Upgrade
|
| Working Capital | 16.48 | 23.31 | 43.62 | 37.5 | 8.18 | Upgrade
|
| Book Value Per Share | -0.51 | -0.25 | 0.17 | 0.64 | 0.17 | Upgrade
|
| Tangible Book Value | -38.86 | -15.91 | 10.61 | 37.98 | 8.76 | Upgrade
|
| Tangible Book Value Per Share | -0.51 | -0.25 | 0.17 | 0.64 | 0.17 | Upgrade
|
| Machinery | 2.03 | 0.85 | 0.61 | 0.53 | 0.53 | Upgrade
|
| Construction In Progress | 1.87 | 2.59 | 0.53 | - | - | Upgrade
|
| Leasehold Improvements | 0.48 | 0.48 | 0.48 | 0.67 | 0.67 | Upgrade
|
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.